Clear market notes built around the JSE, the rand, and what matters locally.

2026-08-03 22:20 • The Motley Fool Positive Axe Cap view: Selective

Sally Beauty Holdings reported progress in its turnaround strategy with net sales up 0.2% to $935 million in Q3, comparable sales growth of 1.6%, and strong e-commerce performance with online sales up 11%. The company improved profit margins, generated $62 million in free cash flow, and increased adjusted EPS by 8% to $0.55. Management projects full-year sales of $3.7 billion and EPS of $2.04-$2.08, with plans to expand into new categories like fragrances and men's products.

Axe note: Strong Q3 results and e-commerce growth fuel optimism in Sally Beauty’s recovery.

2026-08-03 22:06 • The Motley Fool Negative Axe Cap view: Selective

The Magnificent Seven tech giants face a critical dilemma in 2026: companies aggressively investing in AI infrastructure report negative free cash flow, while those maintaining normal capex levels trade at unsustainable valuations. Most underperformed the S&P 500 year-to-date, with only Apple outperforming, leaving investors to choose between betting on AI-driven growth or accepting inflated valuations.

Axe note: Tech giants face a tough 2026 choice—bet heavily on AI with negative cash flow or stay expensive and underdeliver.

2026-08-03 22:05 • The Motley Fool Mixed Axe Cap view: Selective

Supernus Pharmaceuticals announced a merger with Indivior Pharmaceuticals in an all-stock deal, creating a combined company with 11 FDA-approved drugs and anticipated $125 million in annual cost synergies. The stock rose 3% despite initial gains of 16%, reflecting cautious optimism. Q2 earnings showed 32% revenue growth to $219 million but a net loss of $58 million, missing earnings estimates while beating revenue forecasts.

Axe note: A US pharma merger lifts shares but offers limited direct impact for JSE investors.